Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002310916 | SCV000319479 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2018-12-11 | criteria provided, single submitter | clinical testing | The p.A926D variant (also known as c.2777C>A), located in coding exon 21 of the FBN2 gene, results from a C to A substitution at nucleotide position 2777. The alanine at codon 926 is replaced by aspartic acid, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Center for Human Genetics, |
RCV000659607 | SCV000781446 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001315396 | SCV001505967 | likely benign | Congenital contractural arachnodactyly | 2023-11-19 | criteria provided, single submitter | clinical testing |